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Abstract
Background: 3,4-Dihydroxyphenylalanine decarboxylase (DDC), also known as aromatic L-amino acid decarboxylase,
catalyzes the decarboxylation of a number of aromatic L-amino acids. Physiologically, DDC is responsible for the
production of dopamine and serotonin through the decarboxylation of 3,4-dihydroxyphenylalanine and 5-hydroxy-
tryptophan, respectively. In insects, both dopamine and serotonin serve as classical neurotransmitters, neuromodu-
lators, or neurohormones, and dopamine is also involved in insect cuticle formation, eggshell hardening, and immune
responses.
Principal Findings: In this study, we expressed a typical DDC enzyme from Drosophila melanogaster, critically analyzed its
substrate specificity and biochemical properties, determined its crystal structure at 1.75 Angstrom resolution, and evaluated
the roles residues T82 and H192 play in substrate binding and enzyme catalysis through site-directed mutagenesis of the
enzyme. Our results establish that this DDC functions exclusively on the production of dopamine and serotonin, with no
activity to tyrosine or tryptophan and catalyzes the formation of serotonin more efficiently than dopamine.
Conclusions: The crystal structure of Drosophila DDC and the site-directed mutagenesis study of the enzyme demonstrate
that T82 is involved in substrate binding and that H192 is used not only for substrate interaction, but for cofactor binding of
drDDC as well. Through comparative analysis, the results also provide insight into the structure-function relationship of
other insect DDC-like proteins.
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Introduction
3,4-Dihydroxyphenylalanine (DOPA) decarboxylase (DDC) is a
pyridoxal-59-phophate (PLP)-dependent enzyme which physiolog-
ically catalyzes the decarboxylation of 3,4-dihydroxyphenylalanine
to dopamine, and 5-hydroxytryptophan (5-HTP) to 5-hydroxy-
tryptamine (serotonin) [1,2]. Because the enzyme catalyzes the
decarboxylation of other aromatic L-amino acids as well, it is
commonly named aromatic L-amino acid decarboxylase. The
enzyme is present in the majority of living species from select
bacteria to humans. DDC from mammals and insects has
attracted significant attention because both dopamine and
serotonin serve as classical neurotransmitters, neuromodulators,
or neurohormones [3,4,5,6]. A DDC inhibitor is being used in
conjunction with DOPA in humans for the treatment of
Parkinson’s disease [7]. In insects DDC occupies a special position
because dopamine is a key precursor in insect cuticle formation
[8,9], eggshell hardening [10,11] and is involved in immune
responses [8,12,13,14,15,16,17].
A protein BLAST (Basic Local Alignment Search Tool) search
using pig DDC sequence shows that Drosophila has at least five
aromatic L-amino acid decarboxylases or DDC-like sequences,
but mammals have only one. In Drosophila, one of the five DDC-
like sequences is the typical DDC, two of the DDC-like sequences
have been proposed to be tyrosine decarboxylases, and the other
two DDC-like sequences have been named a-methyl DOPA-
resistant proteins. The role of tyrosine decarboxylase was proposed
for two of the DDC-like sequences based on the negative effect on
tyramine production of their mutations [18,19,20,21,22], but the
biochemical characteristics of these proposed tyrosine decarbox-
ylases have not been clearly established. The a-methyl DOPA-
resistant protein was named based on the observation that
Drosophila having this protein were resistant to the toxic compound
a-methyl DOPA [23,24,25,26]. The insect DDC-like sequences
share high sequence identity with one another (.40%) and their
level of identity increases to ,50% when only their putative
catalytic domains are compared. The presence of multiple DDC-
like sequences in insects raises an important question – why have
multiple DDC-like sequences evolved in insects and what are their
structure-function relationships? In this study, we determined the
crystal structure of the typical Drosophila DDC (drDDC). Based on
what we found in the structure, we further performed site-directed
mutagenesis of the enzyme, tested the substrate specificity and
identified residues that affect the substrate binding affinity and the
turnover number of the enzyme. Our results provide insight into
substrate specificity for drDDC.
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Biophysical Properties of drDDC Wild-Type (WT) and
Mutant Proteins
Three site directed mutations, T82A, T82S and H192W, as well
as the wildtype drDDC were investigated. Based on SDS-PAGE
analysis, all four recombinant proteins were of high purity (data
not shown). Freezing and thawing did not result in activity changes
of the isolated enzymes. drDDC WT protein was tested for
optimal temperature and pH. It showed maximum activity at 30 to
60uC (Fig. 1a), and at pH 7 (Fig. 1b).
Overall Structure
The structure of drDDC was determined by molecular
replacement and refined to 1.75 A ˚ resolution with excellent
statistics (Table 1). The final model contains 26448 amino acid
residues and yields a crystallographic R value of 19.7% and an
Rfree value of 22.6%. All residues in the two subunits are in
allowed regions of the Ramachandran plot, as defined with
PROCHECK [27]. Table 1 illustrates refinement statistics of
drDDC and the statistics on Ramachandran plot. There are two
protein molecules in an asymmetric unit, which forms a biological
homodimer. The fragment of V322 to P348 of both subunits in the
structure was highly disordered; therefore, they were not included
in the final drDDC model. An overview of the dimeric structure
model is illustrated in Fig. 2a. Each of the two monomers is
composed of three distinct domains (Fig. 2b). The large domain
(Residues 86–380) contains a seven-stranded beta sheet, and the
small domain comprises the C-terminal part of the chain (residues
380–475), which folds into a 4-stranded beta sheet covered with
helices on one side. Based on the above features of the structure,
drDDC is a fold-type I PLP-dependent enzyme [28,29,30,31,32].
In addition to these two domains, drDDC contains an additional
N-terminal domain (residues 1–85). This domain is composed of
two parallel helices and one small helix. This structure lies like a
flap over the top of the second subunit and vice versa, with the first
helix of one subunit aligning antiparallel to the equivalent helix of
the other subunit. The drDDC architecture represents the same
sub-fold type as that of pig DDC [33].
Cofactor Binding Site
The active site of drDDC is located near the monomer-
monomer interface but is composed mainly of residues from one
monomer (Fig. 3). The cofactor PLP binds to K302 through a
Schiff base linkage to form an internal aldimine, lysine-pyridoxal-
5-phosphate (LLP). The carboxyl group of D270 and the
protonated pyridine nitrogen of PLP form a pair of salt bridges,
which is structurally and functionally conserved within fold-type I
of the PLP-dependent enzyme family. The cofactor is further
anchored to the protein through an extended hydrogen bond
network and hydrophobic interaction. The PLP pyridine ring is
stacked between residues A272 on one side and H192 on the other
side. The phosphate moiety of PLP is anchored by polar
interactions with the peptide amide groups of residues A148 and
S149 as well as by the side chains of S149, N299, and two water
molecules. PLP also interacts with one residue from the other
subunit, F103*. All residues involved in PLP binding in drDDC
are conserved with those involved in the PLP binding sites in pig
DDC. Upon superposing the native drDDC structure onto the pig
DDC structure (Fig. 4), we identified a flexible loop in drDDC
structure, which did not superpose well. This loop consists of
residues 98–107 and is closer to the active center than the
counterpart fragment, residues 98–107, of pig DDC. If drDDC
binds a substrate, the loop (residues 98–107) must move away from
the active site. Otherwise, there is not enough room for a substrate
binding in the active center.
Substrate Specificity and Kinetic Properties
Before testing the substrate specificity, we needed to identify a
concentration of PLP that would not be rate-limiting for these
reactions. We tested four concentrations, 0, 20, 40, and 80 mMo f
PLP, for each of the four recombinant proteins. Each enzyme
showed similar activity at 20, 40, and 80 mM PLP in the reaction
mixtures and about the half activity without PLP; thus using
40 mM PLP is sufficient for the enzyme activity assay. Because all
the four recombinant proteins showed activity without adding
exogenous PLP, they are likely to be holoenzymes. After two hours
dialysis against 10 mM potassium phosphate buffer at pH 7.0, the
enzymes still showed about the same activity when tested without
adding exogenous PLP in the reaction mixtures, which suggests
the enzymes are not apoenzymes; therefore we were unable to test
enzyme KM values towards PLP. During the expression and
purification process, PLP became associated with some or most of
the recombinant enzymes by forming an internal aldimine.
Addition of exogenous PLP to the enzyme assay mixture increased
Figure 1. Effect of temperature and pH on drDDC activity. The
activities of recombinant drDDC at different temperatures (A) and at
different pH values (B).
doi:10.1371/journal.pone.0008826.g001
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saturated with PLP; therefore, addition of PLP to the reaction
mixture was necessary to achieve maximum activity for the
enzyme.
Substrate screening revealed that drDDC WT was active to
DOPA and 5-HTP, but had no activity to tyrosine, D-DOPA or
tryptophan. In contrast to mammalian DDC proteins that have
higher catalytic efficiency to DOPA than to 5-HTP [34], drDDC
has much higher affinity (5 times) to 5-HTP than to DOPA and
also has greater catalytic efficiency to 5-HTP than to DOPA
(Table 2). When DL-o-tyrosine (o-tyr) and DL-m-tyrosine (m-tyr)
were used as substrates, production of o-tyramine and m- tyramine
respectively were also observed (Fig. 5). Only the mixed DL forms
of o-tyr and m-tyr are commercially available, but the inability of
DDC to catalyze the decarboxylation of D-DOPA suggests that
drDDC may be active to only the L-form of m-tyr and o-tyr.
The crystal structure of pigDDC revealed that residues T82 and
H192 are involved in substrate binding [33]. Structure alignment
of drDDC and pigDDC demonstrates that drDDC has the same
residues, T82 and H192, in these two positions. So we did a site-
directed mutagenesis study for these two residues to confirm their
roles in substrate binding. Because H192 is implicated in binding
PLP as well, our study could also serve to substantiate its role in
cofactor binding. Biochemical characterization shows all three
mutants, like drDDC WT, show some activity to DOPA, 5-HTP,
m-tyr and o-tyr (Fig. 5), but not to D-DOPA, tyrosine or
tryptophan. However, the specific activity of H192W to all four
substrates was significantly decreased; the specific activity of T82A
mutant to DOPA and o-tyr was decreased and to 5-HTP was
increased; and the specific activity of T82S to DOPA and 5-HTP
was increased (Fig. 5).
Most significantly, all mutants decreased the ligand binding
affinity as evidenced by their increased KM values to all tested
substrates. In particular, the KM of the T82A mutant to DOPA
was more than two fold higher, to m-tyr more than 5 fold higher,
to o-tyr more than 4 fold higher, and to 5-HTP more than 8 fold
higher; the KM of the T82S mutant to DOPA was more than two
fold higher, to m-tyr more than 4 fold higher; and the KM of the
H192W mutant to DOPA was more than two fold higher than
that of drDDC WT to the same substrate. (Table 2) It was
apparent that mutating T82 to alanine or serine significantly
increased the enzyme turnover numbers (kcat) to all the substrates,
from two to seven times, while mutation of H192 to tryptophan
Figure 2. Overall structure and schematic view of one subunit of drDDC. A, A schematic representation of the structure of drDDC dimer. B,
The schematic view of a monomer. The cofactor (LLP) is included in stick. Three parts, large domain (green), small domain (blue) and N-terminal part
(pink) are labeled.
doi:10.1371/journal.pone.0008826.g002
Table 1. Data collection and refinement statistics of drDDC.
Crystal Data
Space Group P21212
Unit Cell
a( A ˚) 105.8
b( A ˚) 108.6
c( A ˚) 86.3
a=b=c (u) 90.0
Data collection
X-ray source BNL
a-X29
Wavelength (A ˚) 1.0809
Resolution (A ˚)
b 1.75 (1.81–1.75)
Total number of reflections 1508, 676
Number of unique reflections 100, 700
R-merge
b 0.06 (0.56)
Redundancy
b 15.1 (11.8)
Completeness (%)
b 98.9 (97.8)
Refinement statistics
R-work (%) 19.7
R-free (%) 22.6
RMS Bond lengths (A ˚)0 . 0 1 4
RMS Bond angles (u)1 . 4 2 3
No. of ligand or cofactor molecules 2 LLP
c
1 GOL
c
No. of water molecules 601
Average B overall (A ˚2) 30.0
RMSD of B-factors for main chain residues (A ˚)0 . 9 0 4
RMSD of B-factors for side chain residues (A ˚)2 . 4 4 4
Statistics on Ramachandran plot (%)
Most favoured regions 91.6
Additional allowed regions 8.1
Generously allowed regions 0.3
aBrookhaven National Laboratory.
bThe values in parentheses are for the highest resolution shell.
cLLP, lysine-pyridoxal-59-phosphate; GOL, glycerol.
doi:10.1371/journal.pone.0008826.t001
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(Table 2)
Discussion
Although there have been numerous studies dealing with insect
DDC, particularly drDDC [2], the structural and biochemical
properties of the enzyme have not been thoroughly analyzed in
any insect species. Insects have more DDC-like sequences than
mammals, which have only one DDC. For example, in D.
melanogaster, Tribolium castaneum, Anopheles gambiae, and Aedes aegypti
genomes, there are at least 5, 6, 7 and 7 DDC-like sequences
respectively. In view of the presence of multiple DDC-like
sequences in insects, a comprehensive understanding of the typical
insect DDC is particularly important, because it is the basis for the
classification of the other DDC-like sequences. We anticipate that
a thorough knowledge of the typical DDC will provide important
insights into the structure-function relationships of the other DDC-
like sequences. Although partially purified drDDC has been
documented as showing decarboxylation activity to tyrosine [35],
we did not detect any decarboxylation activity to tyrosine using
our purified recombinant drDDC. This finding, that drDDC has
high activity to DOPA and 5-HTP and no activity to tyrosine, is
consistent with a previous genetic study showing that drDDC is
responsible for dopamine and serotonin production in Drosophila,
but has no role in octopamine synthesis [36].
In contrast to pig DDC which shows higher affinity to DOPA
than to 5-HTP [34], our data showed that drDDC had the highest
affinity and catalytic efficiency to 5-HTP, although its turnover
number for 5-HTP is lower than that for DOPA. Differences in
the levels of DOPA or dopamine versus 5-HTP or serotonin in the
brains of various species may be related to the differences in
behavior among the various DDCs in terms of substrate specificity
to 5-HTP and DOPA, possibly by requiring an enzyme to have a
preferential affinity to compensate for lower levels of a particular
substrate or product. For example, where the Drosophila brain has
much higher levels of dopamine (600 pg/head) than serotonin (170
pg/head) [37], drDDC may be compensating with its greater
Figure 3. The drDDC active site. A stereo view of the active site in the drDDC structure. The LLP and the protein residues within a 4 A ˚ distance of
the cofactor are shown. Only the 2Fo - Fc electron density map covering the LLP is shown contoured at the 1.8 sigma. Hydrogen bonds are shown in
dashed lines.
doi:10.1371/journal.pone.0008826.g003
Figure 4. Superposition of drDDC structure onto pig DDC structure. The protein portions within 12 A ˚ of the active center are shown in the
schematic representation in stereo. Pig DDC and drDDC chain As are colored in cyan and magenta, respectively; and their chain Bs are colored in
deep teal and brown, respectively.
doi:10.1371/journal.pone.0008826.g004
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brain, although the dopamine level is much higher than serotonin
(135 vs 5 pg/mg protein) in the striatum, dopamine levels are lower
than serotonin (0.7 vs 3.9 pg/mg protein) in the frontal cortex [38],
where the serotonergic and dopaminergic neurons co-exist.
Mammalian DDC may be compensating for these levels with a
greater affinity for DOPA.
Although we determined the crystal structure of drDDC with
the cofactor, PLP, at high resolution, we did not get a complex
structure binding a substrate. The inability to obtain a crystal
structure of substrate-bound enzyme might be a result of substrate
turn-over by the enzymatic catalysis. To fully understand the
mechanism of catalysis and substrate specificity, it will be
necessary to co-crystallize the proteins (wild type and mutant
drDDC) with an inhibitor or to perform molecular docking with
consideration of protein conformational change. However, by
superposing drDDC structure onto a pig DDC complex structure
bound with the anti-Parkinson drug carbiDOPA [33], we were
able to identify putative substrate binding residues of drDDC.
Based on the information in the pig DDC-carbiDOPA complex,
where the T82 residue forms a hydrogen bond with 4-catechol
hydroxyl group of carbiDOPA (Fig. 6a), the corresponding
threonine residue in drDDC is suspected to interact with a
substrate. To provide more evidence of the role of T82 we did a
site-directed mutagenesis study to see if altering T82 could affect
the substrate binding. Usually, the dissociation constant is used to
describe the affinity between a ligand and a protein. In the present
study, we did not determine the dissociate constant of protein-
ligand binding, but KM values which are also indicative of the
binding affinity between a substrate and an enzyme, with a lower
value suggesting a higher binding affinity. The biochemical change
of the mutants with replacement at T82 was smaller than
expected. However, the KM values of the mutants are changed
by more than two fold for DOPA, which demonstrates that the
binding affinity is changed by site-directed mutagenesis of T82.
These results confirmed that T82 was involved in the substrate
binding. But, it is not the residue determining the enzyme
substrate affinity for DOPA as opposed to tyrosine. Structural
alignment of drDDC, pig DDC, Drosophila tyrosine decarboxylase-
1 and Drosophila tyrosine decarboxylase-2 shows that at the position
of T82, both drDDC and pig DDC have a threonine residue,
Drosophila tyrosine decarboxylase-1 has a serine residue and
Drosophila tyrosine decarboxylase-2 has an alanine residue.
(Fig. 6b) It appeared that T82 might be a critical residue to
Figure 5. Molecular structures of tested chemicals and
decarboxylation activity of drDDC WT and three mutants
towards different aromatic amino acid substrates. A, Molecular
structures of tyr (tyrosine), o-tyr, m-tyr, DOPA, trp (tryptophan) and 5-
HTP; B, Decarboxylation activity. A typical reaction mixture of 100 ml
consists of 5 mg of purified drDDC WT or any mutants, 1 mM of DOPA,
5-HTP, m-tyr, o-tyr, trp, tyr or d-DOPA, and 40 mM PLP in 150 mM
potassium phosphate buffer, pH 7.0. Vertical axis shows the specific
activity of the enzymes to each substrate (trp, tyr, and d-DOPA are not
shown because none of the proteins showed any activity to them), and
horizontal axis shows the drDDC WT and mutant protein names.
doi:10.1371/journal.pone.0008826.g005
Table 2. Kinetic parameters of drDDC WT and mutant
proteins towards different substrates.
KM mM kcat min
21 kcat /KM min
21mM
21
Dopa
WT 2.260.3 28261.6 128.2
T82A 5.6615 2 4 644.2 93.6
T82S 4.560.9 672.6661.9 149.5
H192W 4.460.8 93.269.7 21.2
m-tyr
WT 2.361.2 213.8640.4 93
T82A 13.364.5 859.86179 64.6
T82S 11.462.2 690.5680.2 60.6
H192W 2.661.1 63.569.6 24.4
o-tyr
WT 1.160.3 110.868 100.7
T82A 4.961.5 319.9643 65.3
T82S 1.960.7 225.7628.2 118.8
H192W 1.960.4 38.762.5 20.4
5-HTP
WT 0.460.04 62.861.4 157
T82A 3.560.5 440.4623.4 125.8
T82S 0.660.1 102.663 171
H192W 1.160.1 32.460.8 29.4
The activities were measured as described in Materials and Methods. The KM
and kcat for different substrates were derived by using varying concentrations
(0.1 to 12 mM)) of individual substrates. The parameters were calculated by
fitting the Michaelis–Menten equation to the experimental data using the
enzyme kinetics module. Results are means 6 SE.
doi:10.1371/journal.pone.0008826.t002
Dopa Decarboxylase
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similar position might recognize tyrosine. However, as with
drDDC WT, the T82A and T82S mutants had no activity to
tyrosine, suggesting that other critical residues are responsible for
tyrosine binding. Furthermore, the pig DDC/carbiDOPA com-
plex suggests that T82 may not be the critical residue which
specifically recognizes DOPA, instead of tyrosine because T82
interacts with the p-hydroxyl group of carbiDOPA, which is
present in both dopa and tyrosine. In the pig DDC/carbiDOPA
complex, the NE atom of His302 forms a hydrogen bond (3.8 A ˚)
with the 3-catechol hydroxyl group of carbiDOPA, and is only
4.2 A ˚ away from the 4-catechol hydroxyl group of carbiDOPA
[33]. The corresponding residue of His302 of pig DDC is His301
in drDDC, and Asn in two Drosophila tyrosine decarboxylases. It is
possible that His301 in drDDC might be involved in DOPA
recognition and the corresponding Asn residue in Drosophila
tyrosine decarboxylases might be responsible for the recognition of
tyrosine. Therefore, further sited-mutagenesis studies of His301
might provide further insight into the substrate specificity of
drDDC and Drosophila tyrosine decarboxylases. Because the
current structure is not a substrate-bound complex and a fragment
near the active center is missing, further studies will be necessary to
fully understand the substrate selection/recognition mechanisms
of drDDC.
The crystal structure of drDDC shows that H192 interacts with
the co-factor PLP pyridine ring. There is evidence that H192 may
also interact with the enzyme substrate, as the corresponding
histidine residue in pig DDC forms a hydrogen bond with a
substrate like inhibitor (Fig. 6c). The alignment of drDDC, pig
DDC, Drosophila tyrosine decarboxylase-1 and Drosophila tyrosine
decarboxylase-2 shows that this residue is strictly conserved in all
of these enzymes (Fig. 6b). Site directed mutation substituting
tryptophan for the histidine residue, H192W, significantly
decreased the activity, as well as the affinity evidenced by KM
change, to all the tested substrates. Although the tryptophan
residue in the mutant should interact with the PLP pyridine ring in
a manner similar to histidine residue of the wildtype, its larger size
may also occupy the space for substrate binding, rendering it
unable to form a hydrogen bond with a substrate. Compared to
T82 mutations, the H192W mutation caused changes in the
kinetic properties of drDDC, especially regarding the kcat value
(Table 2). The PLP pyridine ring is stacked between H192 and
A272; therefore, the H192W mutation may cause changes in the
torsion between the pyridine ring and Lys-derived imine bond.
This could affect the turnover number as well.
In summary, a specific DDC enzyme from fruit flies, drDDC
has been functionally expressed, and its substrate specificity,
optimal pH, temperature and crystal structure have been
determined. A further site-directed mutagenesis study provides a
reasonable biochemical and structural basis to propose T82 is
involved in substrate binding and H192 is used not only for
substrate interaction, but also for co-factor PLP binding of
drDDC.
Materials and Methods
Chemicals
DOPA, D-DOPA, dopamine, L-tryptophan, 5-HTP, L-5-
hydroxytryptamine, tyrosine, o-tyr, m-tyr, PLP and others were
purchased from Sigma-Aldrich (St. Louis, MO, USA). All amino
acids used in the experiment are L-form unless otherwise specified.
First-Stand Drosophila cDNA Synthesis and Amplification
of drDDC WT
Total RNA was isolated from Drosophila melanogaster larvae and
pupae using TRIZOL reagent (Invitrogen, Carlsbad, CA) based
on manufacturer’s instruction and used to synthesize first-stranded
cDNA. Oligonucleotide primers (Table 3) were synthesized and
used for amplification of drDDC (NP_724164) from the
synthesized fly cDNA pool.
Expression and Purification of drDDC WT and Mutants
The amplified cDNA product for WT drDDC was cloned into
an Impact
TM-CN plasmid (New England Biolabs) for expression of
a fusion protein containing a chitin-binding domain. The frame
and orientation of the DDC insert were verified by sequencing.
T82A, T82S and H192W mutant recombinant DDC plasmids
were prepared using recombinant drDDC Impact
TM-CN plasmid
as a template by a QuikChange kit (Stratagene, USA) using the
oligonucleotide primers listed in Table 3. Escherichia coli DE3
competent cells were transformed with the recombinant plasmids
(containing WT or a mutant DDC sequence). Transformed
Figure 6. The roles of T82 and H192. A, Superposition of drDDC
structure onto pig DDC structure shows that T82 of drDDC is a
putative substrate binding residue. Residues from pig DDC are
c o l o r e di nc y a na n dt h o s ef r o md r D D Ca r ec o l o r e di nm a g e n t a .B,
Alignment of drDDC, pig DDC, Drosophila tyrosine decarboxylase-1
(drTDC-1) and Drosophila tyrosine decarboxylase-2 (drTDC-2). The
corresponding residues of T82 and H192 are labeled. C, Superposition
of drDDC structure onto pig DDC structure shows the H192 of drDDC
is a putative substrate and cofactor binding residue. Residues from
p i gD D Ca r ec o l o r e di nc y a na n dt h o s ef r o md r D D Ca r ec o l o r e di n
magenta.
doi:10.1371/journal.pone.0008826.g006
Dopa Decarboxylase
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IPTG, the cells were cultured at 15uC for 24 hrs. The soluble
fusion proteins were applied to a column packed with chitin beads
and subsequently hydrolyzed under reducing conditions. The
affinity purification resulted in the isolation of each individual
recombinant protein at about 80% purity. Further purifications of
the recombinant proteins were achieved by DEAE-Sepharose,
Mono-Q and gel-filtration chromatographies. Purified recombi-
nant DDC WT and T82A, T82S, H192W mutants were
concentrated to 10 mg ml
21 protein in 10 mM phosphate buffer
(pH 7), containing 40 mM PLP using a Centricon YM-50
concentrator (Millipore). Purity of the recombinant proteins was
evaluated by SDS-PAGE and the concentration of the purified
recombinant proteins was determined by a Bio-Rad protein assay
kit (Hercules, CA) using bovine serum albumin as a standard.
Effect of pH and Temperature on drDDC WT
To determine the effect of buffer pH on activity of drDDC WT
protein, a 100 mL buffer mixture consisting of 100 mM phosphate
and 100 mM boric acid was prepared and the pH of the buffer
was adjusted to 6.0, 7.0, 8.0, 9.0, 10.0 and 11.0. 1 mM DOPA,
5 mg drDDC WT and 40 mM PLP were used in the reaction
mixtures. To determine the effect of temperature, 100 mL of the
same reaction mixture was used but with a different buffer
(150 mM potassium phosphate buffer, pH 7.0). The mixture was
incubated at temperatures ranging from 10–80uC for 10 min.
During the mixture preparation for optimal temperature tests,
drDDC WT protein was pre-incubated at the applied temperature
for 1 min.
Crystallization
The crystals were grown by hanging-drop vapor diffusion
methods with the volume of reservoir solution at 500 ml and the
drop volume at 2 ml, containing 1 ml of protein sample and 1 mlo f
reservoir solution. The optimized crystallization buffer consists of
15% PEG 4000, 20% glycerol, 200 mM CaCl2, and 100 mM
Cacodylic acid, pH 6.5.
Data Collection and Processing
Diffraction data of drDDC crystals were collected at the
Brookhaven National Synchrotron Light Source beam line
X29A (l=1.0908A ˚). Data were collected using an ADSC
Q315 CCD detector. All data were indexed and integrated
u s i n gH K L- 2 0 0 0s o f t w a r e .S c a l i n ga n dm e r g i n go fd i f f r a c t i o n
data were performed using the program SCALEPACK [39].
The parameters of the crystals and data collection are listed in
Table 2.
Structure Determination
The structure of DDC was determined by the molecular
replacement method using the published pig DDC structure
(Protein Data Bank code, 1js3) [33]. The program Molrep [40]
was employed to calculate both cross-rotation and translation of
the model. The initial model was subjected to iterative cycles of
crystallographic refinement with the Refmac 5.2 [41] and graphic
sessions for model building using the program O [42]. The
cofactor molecule was modeled when the R factor dropped to a
value of around 0.24 at full resolution for the structures, based
upon both the 2Fo–Fc and Fo–Fc electron density maps. Solvent
molecules were automatically added and refined with ARP/wARP
[43] together with Refmac 5.2.
Structure Analysis
Superposition of structures was done using Lsqkab [44] in the
CCP4 suite. Figures were generated using Pymol [45]. Protein and
substrate interaction also was analyzed using Pymol [45].
Substrate Screening
A typical reaction mixture of 100 ml consisted of 5 mg of purified
WT or mutant drDDC, 1 mM of DOPA, tyrosine, L-tryptophan,
5-HTP, m-tyr, o-tyr or D-DOPA, and 40 mM PLP in 150 mM
potassium phosphate buffer, pH 7.0. The reaction mixture was
incubated for 10 min at 38uC and the reaction was stopped by
adding an equal volume of 0.8 M formic acid into the reaction
mixture. The mixture was centrifuged for 10 min at 15,000 g and
supernatant (5 ml) was injected into a high-performance liquid
chromatography reverse-phase column (15064.6 mm, Varian,
Palo Alto, CA) for analysis. The formation of decarboxylated
products was monitored by an in-line UV detector. The formation
of serotonin from 5-HTP and tryptomine from L-tryptophan was
detected at a wavelength of 275 nm; dopamine from DOPA or D-
dopa at 230 nm; tyramine from tyrosine, o-tyramine from o-tyr
and m-tyramine from m-tyr at 225 nm.
Kinetic Analysis
Once the activity of drDDC WT or a mutant protein with a
tested substrate was verified, the kinetic parameters of drDDC WT
and each mutant protein to the substrates were determined by
incubating the protein in the presence of varying concentrations
(0.1 to 12.0 mM) of the substrates at 38uC in a water bath
incubator. The kinetic parameters were determined from the
velocities of enzymatic reactions at different concentrations of
substrates using the Michaelis–Menten equation by a non-linear
regression method (Enzyme Kinetic Module in SigmaPlot 8,
SYSTAT).
The atomic coordinate and structure factor (code: 3K40) have
been deposited in the Protein Data Bank, Research Collaboratory
for Structural Bioinformatics, Rutgers University, New Brunswick,
NJ (http://www.rcsb.org).
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Table 3. Oligonucleotide primers used for drDDC
amplification and site-directed mutagenesis.
Primer Sequences
WT Fw 59-AAAACATATGGAGGCGCCGGAGTTCAA-39
Rv 59-AAAAGAATTCACTGCTCCTGTTCCATCTCG-39
T82A Fw 59-AAGTTTCATGCCTACTTCCCCGCAGCCAACTCGTATCCAGC-
GATC-39
Rv 59-GATCGCTGGATACGAGTTGGCTGCGGGGAAGTAGGCATGA-
AACTT-39
T82S Fw 59-AAGTTTCATGCCTACTTCCCCAGTGCCAACTCGTATCCAGC-
GATC-39
Rv 59-GATCGCTGGATACGAGTTGGCACTGGGGAAGTAGGCATGA-
AACTT-39
H192W Fw 59-TACTGCTCGGACCAGGCTTGGTCATCCGTGGAGCGGGCTG-
GTCTT-39
Rv 59-AAGACCAGCCCGCTCCACGGATGACCAAGCCTGGTCCGA-
GCAGTA-39
doi:10.1371/journal.pone.0008826.t003
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